Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

Functional Subtyping With 80-Gene Assay Identifies Distinct Triple-Positive Subtypes in Breast Cancer Patients

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

For more information on breast care topics, please visit https://www.breastcarenetwork.com/.

Research Studies

National Principal Investigator

American Society of Breast Surgeons Mammosite Registry Trial 2003-2013

EXIBT Registry – A Post Market Study of the Xoft Axxent Electronic Brachytherapy (EBT) System for Treatment of Early Stage Breast Cancer – April 2008-present

NBRST – Neo-adjuvant Breast Symphony Trial – Subtyping and response to neo-adjuvant chemotherapy 2013-present

Universal Breast Cancer Genetic Registry 2017- 18

Informed Genetically Annotated Patient (iGAP) Registry 2019 – present

Local Principal Investigator – National Trials

Melanoma

Sunbelt Melanoma Trial: A Multicenter Trial of Adjuvant Interferon Alfa 2b for Melanoma Patients with Early Lymph

Node Metastasis Detected by Lymphatic Mapping and Sentinel Lymph Node Biopsy Sponsor Univ of Louisville 1998-2012

Multicenter Selective Lymphadenectomy Trial II: A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients with Molecular or Histopathological Evidence of Metastases in the Sentinel Node. Sponsor John Wayne Cancer Institute 2005-present

E1697 – Phase III Randomized Study of Four Weeks High Dose IFN-α2b in Stage T2b N0, T3a-b N0, T4a-b N0, and T1-4 N1a-2a (microscopic) Melanoma 2009-2019

MORD-STG4SURG-0409: A Phase III, Randomized Trial of Surgical Resection With or Without BCG Versus Beast Medical Therapy as Initial Treatment in Stage IV Melanoma August 2010-2013

103A-301: A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients with a High Risk of Recurrence (MAVIS = Melanoma Antigen Vaccine Immunotherapy Study) July 2012-present

Breast

Multicenter Breast Sentinel Node Validation Trial Sponsor Univ of Vermont 1996-98

American College of Surgeons Oncology Group Z0010 – A Prognostic Study of Study of Sentinel Node and Bone Marrow Micrometastases in Women with Clinical T1 and T2 NOMO Breast Cancer 1998-present American College of Surgeons Oncology Group Z0011 – A Randomized Trial of Axillary Node Dissection in Women with Clinical T1 and T2 NOMO Breast Cancer and a Positive Sentinel Node 1998-present

NAFTA – A Phase III Study of Tamoxifen versus Toremifene as Adjuvant Therapy for Women with Carcinoma of the

Breast. Sponsor Univ of Louisville 1998-2008

Visica Treatment System Fibroadenoma CryoAblation Treatment Registry, Sponsor Sanaurus 2002-2004.

NSABP B35 A Clinical Trial Comparing Anastrozole with Tamoxifen in Postmenopausal Patients with Ductal

Carcinoma in Situ (DCIS) Undergoing Lumpectomy with Radiation Therapy. 2003-present

Gene Search Brest Lymph Node (BLN) Assay for Intra-Operative Molecular Testing. Sponsor Veridex 2003-2007

Comparative Evaluation of CryoAssisted Lumpectomy vs. Needle Wire Localization Trial for Breast Lumpectomy.

Sponsor Sanauras 2003-2006

A Phase I, Open Label Study of the Safety, Pharmacokinetics and Pharmacodynamics of GW572016 in Once Daily

Versus Twice Daily Dosing Regimens in Patients with Treatment Naïve Breast Cancer Sponsor GlaxoSmithKline 2004-2008

A Technical Study to Determine the Accessibility Rate of Core and Fine Needle Aspiration Biopsies from Breast Cancer

Tissue for Testing in the Precision Therapeutics Chemoresponse Assay. Sponsor Precision Therapeutics 2004-2007

American College of Surgeons Oncology Group Z1031 A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane, Letrozole, or Anastrozole in Postmenopausal Women with Clinical Stage II and III Estrogen Receptor Positive Breast Cancer –2005-present

Sysmex Study – A Clinical Evaluation of LS-03M/LS-04R for the Detection of Sentinel Lymph Node Metastasis from Breast Cancer 2006-2008

Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial. Sponsor Eastern Cooperative Oncology Group – 2007-present

Molecular Characteristics of Tumor Cells. Sponsor National Institutes of Health – 2007-9

SenoRx Registry – A Multi-Site Prospective, Non Randomized Study Utilizing the Contura Multi-Lumen Balloon (MLB) Breast Brachytherapy Applicator to Deliver Accelerated Partial Breast Irradiation: Analysis of Dosimetric Success, Local Tumor Control, Cosmetic Outcome, Acute and Chronic Toxicity, and Clinical Scenarios for Optimal Use – May 2008-11

Recovery and Analysis of CTCs and cNAs from Whole Blood of Women with Breast Cancer. Sponsor Biocept, Inc. – July 2008-10

PT-304 – Prediction of Response to Neoadjuvant Chemotherapy in Women with Operable Breast Cancer. Sponsors Department of Defense/Precision Therapeutics, Inc. – December 2009 – September 2012

Nipple Sparing Mastectomy Registry Program. Sponsor – American Society of Breast Surgeons – April 2011-present

Prospective Neo-Adjuvant Registry Trial Linking MammaPrint, Subtyping and Treatment Respose: Neoadjuvant Breast Registry – Symphony Trial (NBRST). Sponsor Agendia, Inc. – July 2011-present

General Cancer

Solid Tumor Cancer Sentinel Lymph Node Study. Sponsor Univ of Louisville 1998-2001

Cancer Tissue, Adjacent Normal Tissue, Urine and Peripheral Whole Blood. Translational Oncology: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of the Cancer Patient. Sponsor MT Group – December 2006-present

A Registry of Caris Target Now Test Results (Biomarker Expression Patterns) and Hematopoietic Diagnostics for Evaluation of Correlation with Clinical Outcomes for Cancer and other Patients. Sponsor Caris Life Sciences – January 2011-19

Colon Cancer

Registry Trial of the IsoMed Pump Model 8472 for Hepatic Arterial Infusion of Chemotherapy. Sponsor Medtronics, 1998-2000.

Local Principal Investigator – Local Trials

Breast Cancer

Detection of Subclinical Breast Cancer Metastases. Sponsor UT Southwestern 1998-2011.

Book Chapters

Beitsch, P. “Mammosite Balloon Catheter Placement and Other Brachytherapy Delivery Devices.” Atlas of Breast Surgical Techniques. Ed. V. Suzanne Klimberg. Philadelphia: Saunders Elsevier, 2010. 385-399. Print.

Beitsch, P. “Breast Brachytherapy Device Placement.” Master Techniques in General Surgery – Breast Surgery. Ed. Kirby Bland and V. Suzanne Klimberg. Philadelphia: Lippincott Williams & Wilkins, 2011. 237-252. Print.

Publications

  1. Beitsch PD, Fuchshuber P, Lotzova E. Cytotoxic Factor Produced in Long Term Interleukin 2 Cultures. Cellular and Molecular Targets of Cancer Therapy. October 24, 1989.
  2. Beitsch PD, Fuchshuber P, Lotzova E. Cytotoxic Factor Production by IL-2 Cultured Lymphocyte Subpopulations. Proceedings of the 15th International Cancer Research. 1990; Vol. 31, Page 242.
  3. Beitsch PD, Fuchshuber P, Lotzova E. Identification of Lymphocyte Subsets Responsible for Cytotoxic Factor Production in IL-2 Cultures of Human Blood and Bone Marrow Lymphocytes. Proceedings of the 15th International Cancer Congress, July, 1990.
  4. Beitsch PD, Lotzova E, Pollock R. Surgery Induced Impairment of Natural Immunity in Breast Cancer Patients. Breast Cancer Research and Treatment. October, 1991; Vol. 19, No. 2, Page 206.
  5. Beitsch PD, Lotzova E, Hortabagyi G. Neoadjuvant Chemotherapy Induced Impairment of Natural Immunity in Breast Cancer Patients. Proceedings of the American Association of Cancer Research. 1992; Vol. 33, Page 937.
  6. Beitsch PD and Balch CM. Operative Morbidity and Risk Factor Assessment in Inguinal Lymph Node Dissection for Melanoma Patients. American Journal of Surgery. 1992; Vol. 164, Page 462-466.
  7. Beitsch PD, Lotzova E, Hortabagyi G, Pollock R. Natural Immunity in Breast Cancer Patients During Neoadjuvant Chemotherapy and after surgery. Surgical Oncology. 1994; Vol.3, No. 2, Page 211.
  8. Beitsch PD, Flynn E, Easley S, Weigelt JA. The Role of Physical Exam and Arteriography in Patients with Penetrating Zone II Neck Wounds. Archives of Surgery. 1994; Vol. 129, Page 577-581.
  9. Beitsch PD and Morton DL. Increased Role of Inguinal Recurrence after Inadequate Inguinal Lymph Node Dissection in Melanoma. Proceedings- 47th Annual Society of Surgical Oncology Cancer Symposium, Houston, TX; March 19,1994.
  10. Beitsch PD, Kirgan DM, Guenther JM, et al. Improved Microstaging of axillary lymph nodes in breast cancer. Breast Cancer Res Treatment, 1994.
  11. Krag DN, Weaver DL, Ashikago T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow SP, Beitsch PD. The Sentinel Node in Breast-Conserving Therapy: A Multicenter Validation Study. New England Journal of Medicine. October 1, 1998, Vol. 339, Pages 941-946.
  12. Nwariaky F, Euhus DM, Beitsch PD, Clifford E, Erdman W, Mathews D, Albores-Saavedra J, Leitsch MA, Peters GN. Sentinel Lymph Node Biopsy, An Alternative to Elective Axillary Dissection for Breast Cancer. American Journal of Surgery, December, 1998; Vol. 176, No. 6, Pages 529-531.
  13. Clifford E and Beitsch PD. Failure of Sentinel Lymph Node Dissection in the Previous Irradiated Breast, (S.11.04) European Journal of Nuclear Medicine, April, 1999, Vol. 26 (supplement), Page S72.
  14. Beitsch PD, Clifford E, Whitworth P. Improved Lymphatic Mapping Technique for Breast Cancer, European Journal of Nuclear Medicine, April, 1999, Vol 26 (supplement), Page S87.
  15. Krag DN, Beitsch PD, Moss TJ, Kusminsky RE, Feldman S, Carp Ned Z, Moffatt FL Jr, Frazier Tg, Gaskin TZ, Shook JW, Harlow SP, Weaver DL, Breast Cancer Cells in the Blood, Breast Journal, Nov/Dec, 1999, Vol 5, Page 354-358.
  16. Beitsch PD and Clifford EJ. Detection of Carcinoma Cells in the Blood of Breast Cancer Patients, American Journal of Surgery, 180 (2000) 446-449.
  17. Beitsch PD, Clifford EJ, Whitworth P, and Abarca A. Improved Lymphatic Mapping Technique for Breast Cancer. Accepted. The Breast Journal, Vol 7, Number 4, 2001: 219-223.
  18. Fehm T, Sagalowsky A, Clifford E, Beitsch PD, et al. Cytogenetic Evidence That Circulating Epithelial Cells in Pateints with Carcinoma Are Malignant, Clinical Cancer Research, Vol 8, 2073-84, July 2002.
  19. Roberts CA, Beitsch PD, Litz CE, et al, Interpretive disparity among pathologists in breast sentinel lymph node evaluation, American Journal of Surgery, 186 (2003) 324-29.
  20. Beitsch PD, Lerner AG, Laidley AL, Tafra L, Edwards MG. Who are we and what do we think? American Journal of Surgery, 186 (2003) 321-323.
  21. Litz CE, Beitsch PD, Clifford EC, Roberts CA, Ewing GE. Intraoperative Cytologic Diagnosis of Breast Sentinel Lymph Nodes in the Routine Setting: A Highly Specific Test with Limited Sensitivity. The Breast Journal , Vol 10 (5) 2004, 383-387.
  22. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, Morrison L, Herlyn D, Terstappen LW, Fleming T, Fehm T, Tucker T, Lane N, Wang J, Uhr J. HER-2 gene amplification can be acquired as breast cancer progresses. Proceedings of the National Academy of Sciences USA. June, 2004; 101 (25): 9393-98.
  23. McMasters KM, Noyes RD, Reintgen DS, Goydos JS, Beitsch PD, Davidson BS, Sussman JJ, Gershenwald JE, Ross MI. Lessons learned from the Sunbelt Melanoma Trial. Journal of Surgical Oncology. July, 2004; 86(4): 212-23.
  24. Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P, Fine R, Haffty B, Arrambide S. First Analysis of Patient Demographics, Technical Reproducibility, Cosmesis and Early Toxicity by the American Society of Breast Surgeons MammoSiteä Breast Brachytherapy Registry Trial in 1237 Patients Treated with Accelerated Partial Breast Irradiation. Cancer. Sept 15, 2004, 104 (6): 1138-48.
  25. Edwards MJ, Broadwater R, Tafra L, Jarowenki D, Mabry C, Beitsch P, Whitworth P, Martin RC, Oetting L. Progressive adoption of cryoablative therapy for breast fibroadenoma in community practice. The American Journal of Surgery. 2004 Sep;188(3): 221-4.
  26. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch AM, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyln D, Terstappen LWMM, Fehm T, Tucker T, Lane N, Wang J, Uhr JW. Circulating Tumor Cells in Patients with Breast Cancer Dormancy. Clinical Cancer Research, Dec. 2004, Vol 10(24): 8152-62.
  27. Beitsch PD, Taylor, WA, Immunohistochemically Detected Tumor Cells in the Sentinel Lymph Nodes of Patients With Breast Carcinoma. The American Journal of Oncology Review. Dec. 2004, Vol 3: 728-730.
  28. Harlow SP, Krag DN, Julian TB, Ashikaga T, Feldman SA, Klimberg VS, Kusminsky R, Moffat FL, Noyes RD, Weaver DL, Beitsch PD. Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial: A Randomized Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node Negative Breast Cancer. Annals of Surgery.Vol 241 (1) 2005, 48-54.
  29. Vicini, F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P, Fine R, Hafft B, Arrambide L. First Analysis of Patient Demographics, Technical Reproducibility, Cosmesis, and Early Toxicity: Results of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Trial. Cancer. 2005 Sep;104(6):1138-48.
  30. Leitch AM, Beitsch PD, McCall LM, Posther K, Newman LA, Herndon JE 2nd, Hunt KK, Giuliano AE. Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. The American Journal of Surgery. 2005 Oct;190(4): 539-42.
  31. Zannis V, Beitsch PD, Vicini F, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Kuerer H, Whitacre E, Whitworth P, Fine R, Haffty B, Stolier A, Mabie J. Descriptions and Outcomes of Insertion Techniques of a Breast Brachytherapy Balloon Catheter in 1403 Patients Enrolled in the American Society of Breast Surgeons Mammosite Breast Brachytherapy Registry Trial. The American Journal of Surgery. 2005 Oct;190(4): 530-8.
  32. Posther KE, McCall LM, Blumencranz PW, Burak WE Jr, Beitsch PD, Hansen NM, Morrow M, Wilke LG, Herndon JE 2nd, Hunt KK, Giuliano AE. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Annals of Surgery. 2005 Oct; 242(4): 593-9; discussion 599-602.
  33. Tafra L, Fine R, Whitworth P, Berry M, Woods J, Ekbom G, Gass J, Beitsch P, Dodge D, Han, L, Potruch T, Francescatti D, Oetting L, Smith S, Snider H, Kleban D, Chagpar A, Akbari S. Prospective randomized study comparing cryo-assisted and needle-wire localization of ultrasound-visible breast tumors. The American Journal of Surgery 192 (2006) 462-470.
  34. Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ, Chagpar AB, Martin RC, Stromberg AJ, Hagendoorn L, McMasters KM, Sunbelt Melanoma Trial. Gender-related differences in outcome for melanoma patients. Annals of Surgery. 2006 May; 243(5): 693-8; discussion 698-700.
  35. Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, Edwards MJ, Martin CG, Conrad A, Albrecht J, McMasters KM. A Prospective Multi-Institutional Study of Reverse Transcriptase Polymerase Reaction for Molecular Staging of Melanoma. Journal of Clinical Oncology. 2006 Jun;24(18): 2849-2857.
  36. Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E. Two Year Analysis of Treatment Efficacy and Cosmesis by the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial in Patients Treated with Accelerated Partial Breast Irradiation (APBI). Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part 1. Vol 24, No.18S (June 20 Supplement), 2006:529.
  37. Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA, Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite Clinical Trial for ductal carcinoma-in-situ of the breast. Annals of Surgical Oncology. 2006 Jul; 13(7): 967-76.
  38. Keisch M, Vicini F, Beitsch P, Kuerer H, Quiet C, Garcia D, Gittleman M, Zannis V, Haffty B, Mabie J. Two Year Actuarial Analysis of 198 Patients with DCIS Treated with Accelerated Partial Breast Irradiation (APBI): Efficacy, Cosmesis and Toxicity in Patients on the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial. International Journal of Radiation Oncology * Biology * Physics. 1 November 2006 (Vol. 66, Issue 3, Page S213).
  39. Meng S, Tripathy D, Shete S, Ashfaq R, Saboorian H, Haley B, Frenkel E, Euhus D, Leitch M, Osborne C, Clifford E, Perkins S, Beitsch P, Khan A, Morrison L, Herlyn D, Terstappen LW, Lane N, Wang J, Uhr J. uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues. Proceedings of the National Academy of Sciences. 2006 Nov 14; 103(46): 17361-5.
  40. Blumencranz P, Whitworth PW, Deck K, Rosenberg A, Reintgen D, Beitsch P, Chagpar A, Julian T, Sukamal S, Mamounas E, Giuliano A, Simmons R. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. The American Journal of Surgery 194 (2007) 426-432.
  41. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. Journal of Clinical Oncology. 2007 Aug 20; 25(24): 3657-63.
  42. Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P, Fine R, Haffty B, Keisch M. Three-Year Treatment Efficacy by the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial in Patients Treated with Accelerated Partial Breast Irradiation (APBI). Journal of the European Society for Therapeutic Radiology and Oncology. 8-13 September, 2007 (Vol. 84, S1):S50.
  43. Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P, Fine R, Haffty B, Keisch M. Three-Year Treatment Efficacy by the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial in Patients Treated with Accelerated Partial Breast Irradiation (APBI). International Journal of Radiation Oncology * Biology * Physics. October 2007 (Vol. 69, S3):S207.
  44. Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC 2nd, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, McMasters KM. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. Journal of Surgical Research. 2007 Nov; 143(1): 164-8.
  45. Vicini F, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC Jr, Gittleman MA, Zannis VJ, Kuerer HM, Lyden M. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008; 112(4):758-66.
  46. Federico AC, Chagpar AB, Ross MI, Martin RC, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, McMasters KM, Scoggins CR. Effect of Multiple- Nodal Basin Drainage on Cutaneous Melanoma. Archives of Surgery. 2008 Jul 01; 143(7): 632-7; discussion 637-8.
  47. Julian TB, Blumencranz P, Deck K, Whitworth P, Berry DA, Berry SM, Rosenberg A, Chagpar AB, Reintgen D, Beitsch P, Simmons R, Saha S, Mamounas EP, Giuliano A. Novel Intraoperative Molecular Test for Sentinel Lymph Node Metastases in Patients with Early-Stage Breast Cancer. Journal of Clinical Oncology. 2008 Jul 10; 26(20): 3338-45.
  48. Olson J, McCall L, Beitsch P, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Guiliano AE. Impact of Immediate vs. Delayed Axillary Dissection on Surgical Outcomes in Breast Cancer Patients with Positive Sentinel Nodes: Results from the American College of Surgeons Oncology Group (ACOSOG) Trials Z0010 and Z0011. Journal of Clinical Oncology . 2008 Jul 20;26(21):3530-5.
  49. Haffty B, Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P, Fine R, Keisch M. Timing of Chemotherapy after MammoSite Radiation Therapy System Breast Brachytherapy: Analysis of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. International Journal of Radiation * Oncology * Physics. 2008 Aug 7. [Epub ahead of print]
  50. Wong SL, McCahill LE, Edge SB, Askew RL, Beitsch PD, Kollmorgen DR, Anthony T, Petrelli NJ, Leong SP, Cormier JN. Getting to Better Cancer Care: Results of a Society of Surgical Oncology Survey. Annals of Surgical Oncology. 2008 Sep 01; 15(9): 2363-71.
  51. Beitsch PD, Hodge CW, Dowlat K, Francescatti D, Gittleman MA, Israel P, Nelson JC, Potruch T, Snider HC Jr, Whitworth P, Zannis VJ, Patel RR. The Surgeon’s Role in Breast Brachytherapy. The Breast Journal. 2009 Jan 01; 15(1): 93-100.
  52. Khan AJ, Vicini F, Beitsch P, Haffty B, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P Jr, Fine R. Local Control, Toxicity, and Cosmesis in Women Younger than 50 Enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial. Annals of Surgical Oncology. 2009 Jun 01; 16(6): 1612-8.
  53. Nelson JC, Beitsch PD, Vicini FA, Quiet CA, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Whitworth PW, Fine RE, Keleher AJ, Kuerer HM. Four Year Clinical Update from the American Society of Breast Surgeons MammoSite Brachytherapy Trial. American Journal of Surgery. 2009 July; 198(1): 83-91.
  54. Goyal S, Khan AJ, Vicini F, Beitsch PD, Lyden M, Keisch M, Haffty BG. Factors Associated with Optimal Cosmetic Results at 36 Months in Patients Treated with Accelerated Partial Breast Irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Annals of Surgical Oncology. 2009 Sep 01; 16(9): 2450-8.
  55. Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW. Attaining Negative Margins in Breast-Conservation Operations: Is There a Consensus among Breast Surgeons? Journal of the American College of Surgeons. 2009 Nov; 209(5):608-13.
  56. Scoggins CR, Martin RCG, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Noyes RD, Goydos JS, Beitsch PD, Ariyan S, Stromberg AJ, Hagendoorn LJ, McMasters KM. Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients. Annals of Surgical Oncology. 2010 Mar; 17(3):709-17.
  57. Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Haffty B, Kuerer H, Lyden M. Five Year Analysis of Treatment Efficacy and Cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in Patients Treated with Accelerated Partial Breast Irradiation (APBI). International Journal of Oncology, Biology and Physics. 2010 May 14 [Epub ahead of print]
  58. Jeruss JS, Kuerer HM, Beitsch PD, Vicini FA, Keisch M. Update on DCIS Outcomes from the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial. Annals of Surgical Oncology. 2010 June 25 [Epub ahead of print]
  59. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K. Locoregional Recurrence After Sentinel Lymph Node Dissection with or without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: the American College of Surgeons Oncology Group Z0011 Randomized Trial. Annals of Surgery. 2010 Sep;252(3):426-32; discussion 432-3.
  60. Shaitelman SF, Vicini FA, Beitsch P, Haffty B, Keisch M, Lyden M. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer. 2010 Oct 14;116(20):4677-85.
  61. Beitsch PD, Vicini F, Keisch M, Haffty B, Shaitelman S, Lyden M. Five-year Outcome of Patients Classified in the “Unsuitable” Category Using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel Guidelines for the Application of Accelerated Partial Breast Irradiation: An Analysis of Patients Treated on the American Society of Breast Surgeons/Mammosite Registry Trial. Annals of Surgical Oncology. 2010 Oct; 17(3): S219-25.
  62. Boughey JC, Mittendorf EA, Solin LJ, Dixon JM, Tuttle TM, Beitsch PD, Cody HS, Leitch AM, Newman LA. Controversies in Breast Surgery. Annals of Surgical Oncology. 2010 Oct; 17(3): 230-32.
  63. Beitsch PD, Patel RR, Lorenzetti JD, Wurzer JC, Tucker JC, Laduzinsky SJ, Kugler MA. Post-Surgical Treatment of Early-Stage Breast Cancer with Electronic Brachytherapy: an Intersociety, Multicenter Brachytherapy Trial. Journal of OncoTargets and Therapy. 2010 Oct 29;3:211-8.
  64. Goyal S, Vicini F, Beitsch PD, Kuerer H, Keisch M, Motwani S, Jeruss JS, Lyden M, Haffty BG. Ductal Carcinoma In Situ Treated with Breast-Conserving Surgery and Accelerated Partial Breast Irradiation: Comparison of the MammoSite Registry Trial with Intergroup Study E5194. Cancer. 2010 Nov 2. [Epub ahead of print]
  65. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary Dissection vs No Axillary Dissection in Women with Invasive Breast Cancer and Sentinel Node Metastasis: A Randomized Clinical Trial. JAMA. 2011 Feb 9;305(6):569-75.
  66. Beitsch PD, Shaitelman SF, Vicini FA. Accelerated Partial Breast Irradiation. Journal of Surgical Oncology. 2011 Mar 15;103(4):362-8.
  67. Feldman S, Krishnamurthy S, Gillanders W, Gittleman M, Beitsch PD, Young PR, Streck CJ, Whitworth PW, Levine EA, Boolbol S, Han LK, Hermann R, S B Hoon D, Giuliano AE, Meric-Bernstam F; for the US One Step Nucleic Acid Amplification Clinical Study Group. A Novel Automated Assay for the Rapid Identification of Metastatic Breast Carcinoma in Sentinel Lymph Nodes. Cancer. 2011 Jun 15;117(12):2599-607. [Epub 2011 Jan 11]
  68. Beitsch P, Huber T. Community Melanoma Research: From Start Up to Follow Up. Journal of Surgical Oncology. 2011 Sep;104(4):447-51.
  69. Shah C, Wilkinson J, Lyden M, Beitsch P, Vicini F. Predictors of local Recurrence Following Accelerated Partial Breast Irradiation: A Pooled Analysis. Accepted to International Journal of Radiation Oncology*Biology*Physics. 2011 Nov.
  70. Vicini FA, Keisch M, Shah C, Goyal S, Khan AJ, Beitsch PD, Lyden M, Haffty BG. Factors Associated with Optimal Long-Term Cosmetic Results in Patients Treated with Accelerated Partial Breast Irradiation Using Balloon-Based Brachytherapy. International Journal of Radiation Oncology Biology Physics. 2011 Nov 11. [Epub ahead of print]
  71. Aburabia M, Roses RE, Kuerer HM, Fine R, Beitsch PD, Goyal S, Haffty B, Lyden M, Vicini FA. Axillary Failure in Patients Treated with MammoSite Accelerated Partial Breast Irradiation. Annals of Surgical Oncology. 2011 Nov;18(12):3415-21. [Epub 2011 May 3]
  72. Khan AJ, Arthur D, Vicini F, Beitsch P, Kuerer H, Goyal S, Lyden M, Haffty BG. Six-Year Analysis of Treatment-Related Toxicities in Patients treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons Mammosite Breast Brachytherapy Registry Trial. Annals of Surgical Oncology. (2012) 19(5):1477-1483. [Epub 2011 Nov 23]
  73. Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, Norvell F, Phalon C, Taquet N, Rao DD, Wang Z, Jay CM, Pappen BO, Wallraven G, Brunicardi FC, Shanahan DM, Maples PB, Nemunaitis J. Phase I Trial of “bi-shRNAi(furin)/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer. Molecular Therapy: The Journal of the American Society of Gene Therapy. 2011 Dec 20 [Epub ahead of print]
  74. Beitsch P, Patel R, Lorenzetti J, Wurzer J, Tucker J, Laduzinsky S, Kugler M. Post-Surgical Treatment of Early-Stage Breast Cancer with Electronic Brachytherapy: Outcomes and Health-Related Quality of Life at One Year. Manuscript accepted to American Journal of Clinical Oncology 2011.
  75. Shah C, Vicini F, Keisch M, Kuerer H, Beitsch P, Haffty BG, Lyden M. Outcome Following Ipsilateral Breast Tumor Recurrence in Patients Treated with Accelerated Partial Breast Irradiation. Cancer. 2012 Jan 17. [Epub ahead of print]
  76. Gainer S, Hunt K, Beitsch P, Caudle A, Mittendorf E, Lucci A. ACOSOG Z0011 Changing Behavior: Results of a Survey of the American Society of Breast Surgeons. Manuscript accepted to Annals of Surgical Oncology 2012.
  77. Wilkinson JB, Beitsch PD, Arthur D, Shah C, Haffty B, Wazer D, Keisch M, Shaitelman SF, Lyden M, Chen PC, Vicini FA. Patterns of Failure after Accelerated Partial Breast Irradiation by Consensus Panel Group: A Pooled Analysis of William Beaumont Hospital and the American Society of Breast Surgeons Trial Data. Abstract submitted to American Society of Radiation Oncology 2012.
  78. Wilkinson JB, Beitsch PD, Arthur D, Shaitelman SF, Shah C, Haffty B, Wazer D, Keisch M, Lyden M, Vicini FA. Evaluation of Current Consensus Panel Guidelines for APBI: A Pooled Analysis of William Beaumont Hospital and American Society of Breast Surgeons MammoSite Registry Trial Data. International Journal of Radiation Oncology, Biology and Physics. 2012 Oct 4: 1-7.
  79. Dooley W, Wurzer J, Megahy M, Schreiber G, Roy T, Proulx G, Laduzinsky S, Lane S, Dalzell J, Dowlatshahi K, Simmons D, Thropay J, Ahuja H, Beitsch P, Holt R, Lee C. Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis. Onco Targets Ther. 2011;4:13-20. https://doi.org/10.2147/OTT.S15297
  80. Beitsch P, Wilkinson J. Ben, Vicini F, Haffty B, Fine R, Whitworth P, Kuerer H, Zannis V, Lyden M. Tumor Bed Control with Balloon-Based Accelerated Partial Breast Irradiation: Incidence of True Recurrences Versus Elsewhere Failures in the American Society of Breast Surgery MammoSite Registry Trial. Annals of Surgical Oncology. 2012 Sept;19(10):3165-3170. [Epub 2012 Jul 29]
  81. Drukker CA, Nijenhuis MV, Elias SG, Wesseling J, Russell NS, de Snoo F, van’t Veer LJ, Beitsch PD, Rutgers EJT. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer. Cancer Research. 15 Dec 2012; Vol 72, Issue 24, Supplement 3. doi: 10.1158/0008-5472.
  82. Vicini FA, Arthur D, Shah C, Anglin BV, Curcio LD, Laidley AL, Beitsch PD, Whitworth P, Lyden M (2013) Multi-institutional analysis of bioimpedance spectroscopy in the early detection of breast cancer related lymphedema. J Cancer Res Ther 1: 1–7. doi:10.14312/2052-4994.2013-1.
  83. Chirag S, Vicini F, Beitsch P, Anglin B, Laidley A, Ridner S, Lyden M. The use of bioimpedance spectroscopy to monitor response to treatment interventions with breast cancer-related lymphedema. International Journal of Radiation Oncology * Biology Physics. 1 Oct 2013 (Vol. 87, Issue 2, Pg. S574).
  84. Senzer N, Barve M, Nemunaitis J, Kuhn J, Melnyk A, Beitsch P, Magee M, Oh J, Bedell C, Kumar P, Rao D, Pappen B, Wallraven G, Brunicardi F, Maples P, Nemunaitis J. Long Term Follow Up: Phase I Trial of “bi-shRNA furin/GMCSF DNA/Autologous Tumor Cell” Immunotherapy (FANG™) in Advanced Cancer. Journal of Vaccines and Vaccination. 4:209. Doi:10.4172/2157-7560.1000209. 30 Oct 2013.
  85. Beitsch PD, Whitworth PW. Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey. Ann Surg Oncol. 2014 Oct;21(10):
  86. Beitsch PD. American Society of Breast Surgeons Presidential Address: Breast Cancer Surgery is Dead…or Is It? Annals of Surgical Oncology. Ann Surg Oncol. 2014 Oct;21(10)
  87. Whitworth P, Stork-Sloots L, de Snoo FA, Richards P, Rotkiss M, Beatty J, Mislowsky A, Pellicane JV, Nguyen B, Lee L, Nash C, Gittleman M, Akbari S, Beitsch PD. Chemosensitivity Predicted by BluePrint 80-gene Funcational Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). Annals of Surgical Oncology. 2014 Aug 7 [Epub ahead of print
  88. Landercasper J, Attai D, Atisha D, Beitsch P, Bosserman L, Boughey J, Carter J, Edge S, Feldman S, Froman J, Greenberg C, Kaufman C, Morrow M, Pockaj B, Silverstein M, Solin L, Staley A, Vicini F, Wilke L, Yang W, Cody H 3rd. Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol. 2015 Oct;22(10):3174-83. doi: 10.1245/s10434-015-4759-x. Epub 2015 Jul 28.
  89. Baron P, Beitsch P, Boselli D, Symanowski J, Pellicane JV, Beatty J, Richards P, Mislowsky A, Nash C, Lee LA, Murray M, de Snoo FA, Stork-Sloots L, Gittleman M, Akbari S, Whitworth P Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy.Ann Surg Oncol. 2015 Dec 29. [Epub ahead of print
  90. Spector NL, Robertson FC, Bacus S, Blackwell K, Smith DA, Glenn K, Cartee L, Harris J, Kimbrough CL, Gittelman M, Avisar E, Beitsch P, Koch KM. Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor. PLoS One. 2015 Nov 16;10(11):e0142845.
  91. Wobb JL, Chen PY, Shah C, Moran MS, Shaitelman SF, Vicini FA, Mbah AK, Lyden M, Beitsch P. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation.

Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):312-8

  1. McMasters KM, Egger ME, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, Martin RC 2nd, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Davidson BS, Gershenwald JE, Hagendoorn LJ, Stromberg AJ, Scoggins CR. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy. J Clin Oncol. 2016 Apr 1;34(10):1079-86. doi: 10.1200/JCO.2015.63.3776. Epub 2016 Feb 8.
  2. Beitsch PD, Whitworth P. Surgical Breast Specialists 2.0: Rethinking the Future of Breast Fellowship Training. Ann Surg Oncol. 2016 Oct;23(11):3435-3437. doi: 10.1245/s10434-016-5345-6. Epub 2016 Jun 22.
  3. Beitsch P, Whitworth P, Baron P, Pellicane J, Treece T, Yoder E, Gittleman M; NBRST Investigators Group. Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures. Ann Surg Oncol. 2016 Oct;23(10):3317-23. doi: 10.1245/s10434-016-5329-6. Epub 2016 Jul 6.
  4. Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016 Sep;264(3):413-20. doi: 10.1097/SLA.0000000000001863.
  5. Whitworth P, Beitsch P, Mislowsky A, Pellicane JV, Nash C, Murray M, Lee LA, Dul CL, Rotkis M, Baron P, Stork-Sloots L, de Snoo FA, Beatty J. Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping. Ann Surg Oncol. 2017 Mar;24(3):669-675. doi: 10.1245/s10434-016-5600-x. Epub 2016 Oct 21.
  6. Whitworth P, Beitsch P, Arnell C, Cox HC, Brown K, Kidd J, Lancaster JM. Impact of Payer Constraints on Access to Genetic Testing. J Oncol Pract. 2017 Jan;13(1):e47-e56. doi: 10.1200/JOP.2016.013581. Epub 2016 Oct 23.
  7. Beitsch P, Whitworth P, Baron P, Rotkis MC, Mislowsky AM, Richards PD, Murray MK, Pellicane JV, Dul CL, Nash CH, Stork-Sloots L, de Snoo F, Untch S, Lee LA. Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). Ann Surg Oncol. 2017 Sep;24(9):2539-2546. doi: 10.1245/s10434-017-5863-x. Epub 2017 Apr 26.
  8. Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210
  9. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470.
  10. Kwon MJ, Lee SB, Han J, Lee JE, Lee JW, Gong G, Beitsch PD, Nam SJ, Ahn SH, Nam BH, Shin YK. BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer. PLoS One. 2018 Nov 21;13(11):e0207155. doi: 10.1371/journal.pone.0207155. eCollection 2018.
  11. Mitchell SD, Willey SC, Beitsch P, Feldman S. Evidence based outcomes of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry. Gland Surg. 2018 Jun;7(3):247-257. doi: 10.21037/gs.2017.09.10.
  12. Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G, Baron P, Simmons R, Smith LA, Grady I, Kinney M, Coomer C, Barbosa K, Holmes DR, Brown E, Gold L, Clark P, Riley L, Lyons S, Ruiz A, Kahn S, MacDonald H, Curcio L, Hardwick MK, Yang S, Esplin ED, Nussbaum RL. Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle? J Clin Oncol. 2019 Feb 20;37(6):453-460. doi: 10.1200/JCO.18.01631. Epub 2018 Dec 7.
  13. Hughes KS, Beitsch P, Chen S. Guidelines Do Not Proscribe Surgeons Performing Genetic Testing. JAMA Surg. 2019 Mar 1;154(3):269. doi: 10.1001/jamasurg.2018.4882.
  14. Groenendijk FH, Treece T, Yoder E, Baron P, Beitsch P, Audeh W, Dinjens WNM, Bernards R, Whitworth P. Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers. NPJ Breast Cancer. 2019 Apr 18;5:15. doi: 10.1038/s41523-019-0109-7. eCollection 2019
  15. Beitsch P, Hughes K, Whitworth P. Reply to M.S. Copur et al, A. Taylor et al, and P.S. Rajagopal et al. J Clin Oncol. 2019 Aug 20;37(24):2178-2180. doi: 10.1200/JCO.19.00798. Epub 2019 Jun 27.
  16. Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2019 Oct;26(11):3510-3516. doi: 10.1245/s10434-019-07577-4. Epub 2019 Jul 11.
  17. Peter D. Beitsch, Pat W. Whitworth, Kevin S. Hughes, Rakesh Patel, Paul Baron, Barry Rosen, Ian Grady, Dennis Holmes, Rache M. Simmons, Linda Ann Smith, Gia Compagnoni, Cynara L. Coomer, Eric Allen Brown, Karen Barbosa, Patricia Clark, Linsey P. Gold, Lee B. Riley, Edward D. Esplin, Shan Yang, and Robert L. Nussbaum. Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer: Untapped clinical utility and PARP inhibitor trial eligibility Journal of Clinical Oncology 2019 37:15_suppl, 1583-1583
  18. Craig L. Slingluff, Brent A. Blumenstein, Karl D. Lewis, Robert Hans Ingemar Andtbacka, John Robert Hyngstrom, Mohammed M. Milhem, Svetomir Markovic, Omid Hamid, Leonel Fernando Hernandez-Aya, Tawnya Lynn Bowles, Prejesh Philips, Sekwon Jang, Jose Lutzky, Anna Bar, and Peter D. Beitsch. Final analysis of relapse-free survival in a multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine after resection of high-risk melanoma. Journal of Clinical Oncology 2020 38:15_suppl, 10017-10017
  19. Thompson, John F. MD; Haydu, Lauren E. PhD; Uren, Roger F. MD; Andtbacka, Robert H. MD; Zager, Jonathan S. MD; Beitsch, Peter D. MD; Agnese, Doreen M. MD; Mozzillo, Nicola MD; Testori, Alessandro MD; Bowles, Tawnya L. MD; Hoekstra, Harald J. MD, PhD; Kelley, Mark C. MD; Sussman, Jeffrey MD; Schneebaum, Schlomo MD; Smithers, B. Mark MBBS; McKinnon, Gregory MD; Hsueh, Eddy MD; Jacobs, Lisa MD; Schultz, Erwin MD; Reintgen, Douglas MD; Kane, John M. MD; Friedman, Erica B. MD; Wang, Hejing MD; Van Kreuningen, Lisa MS; Schiller, Vicki MD; Elashoff, David A. PhD; Elashoff, Robert MD|; Cochran, Alistair J. MD; Stern, Stacey MS; Faries, Mark B. MD; the MSLT-II Trial Group Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging, Annals of Surgery: April 2021 – Volume 273 – Issue 4 – p 814-820 doi: 10.1097/SLA.0000000000003405
  20. Slingluff CL, Lewis KD, Andtbacka R, Hyngstrom J, Milhem M, Markovic SN, Bowles T, Hamid O, Hernandez-Aya L, Claveau J, Jang S, Philips P, Holtan SG, Shaheen MF, Curti B, Schmidt W, Butler MO, Paramo J, Lutzky J, Padmanabhan A, Thomas S, Milton D, Pecora A, Sato T, Hsueh E, Badarinath S, Keech J, Kalmadi S, Kumar P, Weber R, Levine E, Berger A, Bar A, Beck JT, Travers JB, Mihalcioiu C, Gastman B, Beitsch P, Rapisuwon S, Glaspy J, McCarron EC, Gupta V, Behl D, Blumenstein B, Peterkin JJ. Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence. J Immunother Cancer. 2021 Oct;9(10):e003272.
  21. Whitman, E.D., Koshenkov, V.P., Gastman, B.R., Lewis, D., Hsueh, E.C., Pak, H., Trezona, T.P., Davidson, R.S., McPhee, M., Guenther, J.M. and Toomey, P., 2021. Integrating 31-gene expression profiling with clinicopathologic features to optimize cutaneous melanoma sentinel lymph node metastasis prediction. JCO Precision Oncology, 5, pp.1466-1479.
  22. Thompson, J.F., Haydu, L.E., Uren, R.F., Andtbacka, R.H., Zager, J.S., Beitsch, P.D., Agnese, D.M., Mozzillo, N., Testori, A., Bowles, T.L. and Hoekstra, H.J., 2021. Preoperative ultrasound assessment of regional lymph nodes in melanoma patients does not provide reliable nodal staging: results from a large multicenter trial. Annals of surgery, 273(4), pp.814-820.doi: 10.1136/jitc-2021-003272. PMID: 34599031; PMCID: PMC8488725.
  23. Whitworth, P., Beitsch, P.D., Pellicane, J.V. et al. Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer. Ann Surg Oncol (2022). https://doi.org/10.1245/s10434-022-11666-2
  24. Whitworth, P.W., Beitsch, P.D., Murray, M.K., Richards, P.D., Mislowsky, A., Dul, C.L., Pellicane, J.V., Baron, P.L., Rahman, R.L., Lee, L.A. and Dupree, B.B., 2022. Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy. JCO Precision Oncology, 6, p.e2200197.
  25. Whitworth, P., Beitsch, P.D., Pellicane, J.V., Baron, P.L., Lee, L.A., Dul, C.L., Nash III, C.H., Murray, M.K., Richards, P.D., Gittleman, M. and Budway, R., 2022. Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70-and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer. Annals of Surgical Oncology, 29(7), pp.4141-4152.
  26. Crystal, J.S., Thompson, J.F., Hyngstrom, J., Caracò, C., Zager, J.S., Jahkola, T., Bowles, T.L., Pennacchioli, E., Beitsch, P.D., Hoekstra, H.J. and Moncrieff, M., 2022. Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial. JAMA surgery, 157(9), pp.835-842.
  27. Whitworth, P.W., Beitsch, P.D., Patel, R., Rosen, B., Compagnoni, G., Baron, P.L., Simmons, R., Brown, E.A., Gold, L., Holmes, D. and Smith, L.A., 2022. Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer. JAMA Network Open, 5(9), pp.e2232787-e2232787.
  28. Whitworth, P.W., Beitsch, P.D., Pellicane, J.V., Baron, P.L., Lee, L.A., Dul, C.L., Murray, M.K., Gittleman, M.A., Budway, R.J., Rahman, R.L. and Kelemen, P.R., 2022. Distinct neoadjuvant chemotherapy response and 5-year outcome in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast tumors that reclassify as basal-type by the 80-gene signature. JCO Precision Oncology, 6(1), p.e2100463.
  29. Hwang, E.S., Beitsch, P., Blumencranz, P., Carr, D., Chagpar, A., Clark, L., Dekhne, N., Dodge, D., Dyess, D.L., Gold, L. and Grobmyer, S., 2022. Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence–Guided System: A Nonrandomized Controlled Trial. JAMA surgery, 157(7), pp.573-580.